47 related articles for article (PubMed ID: 32772824)
1. Oligosecretory myeloma with gastrointestinal tract involvement: an unusual presentation and literature review.
Ling VYH; Reddivari S; Joseph AM; Cox R
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35365468
[TBL] [Abstract][Full Text] [Related]
2. Synchronous multiple myeloma and lung adenocarcinoma: A clinical series.
Ye F; Wang H; Li N; Liu A; Chen W
Indian J Pathol Microbiol; 2024 Apr; 67(2):390-395. PubMed ID: 38394428
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of rare entity CD138 negative plasma cell multiple myeloma: the synergy between laboratory and clinician makes the difference.
Assandri R; Inzoli A; Manini A; Fasoli G; Martinelli P; Grassini A
Recenti Prog Med; 2024 May; 115(5):238-242. PubMed ID: 38708535
[TBL] [Abstract][Full Text] [Related]
4. Streptococcus pneumoniae bacteraemia leading to the diagnosis of multiple myeloma.
Shahani S; Shahani L
BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25239987
[TBL] [Abstract][Full Text] [Related]
5. Oligoclonal Pattern/Abnormal Protein Bands in Post-Treatment Plasma Cell Myeloma Patients: Implications for Protein Electrophoresis and Serum Free Light Chain Assay Results.
Singh G
J Clin Med Res; 2017 Aug; 9(8):671-679. PubMed ID: 28725315
[TBL] [Abstract][Full Text] [Related]
6. Secondary plasma cell leukaemia (PCL) with plasmablastic morphology.
Xu K; Nacheva E
J Hematop; 2024 Jun; 17(2):117-119. PubMed ID: 38580782
[TBL] [Abstract][Full Text] [Related]
7. Plasma Cell Myeloma with an Aggressive Clinical Course and Anaplastic Morphology in a 22-Year-Old Patient: A Case Report and Review of Literature.
Elsabah H; Soliman DS; Ibrahim F; Al-Sabbagh A; Yassin M; Moustafa A; Nashwan AM; Nawaz Z; ElOmri HM
Am J Case Rep; 2020 Mar; 21():e920489. PubMed ID: 32152261
[TBL] [Abstract][Full Text] [Related]
8. Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma.
Ravi P; Kumar S; Larsen JT; Gonsalves W; Buadi F; Lacy MQ; Go R; Dispenzieri A; Kapoor P; Lust JA; Dingli D; Lin Y; Russell SJ; Leung N; Gertz MA; Kyle RA; Bergsagel PL; Rajkumar SV
Blood Cancer J; 2016 Jul; 6(7):e454. PubMed ID: 27471870
[TBL] [Abstract][Full Text] [Related]
9. Calvarial multiple myeloma: Raindrop skull.
Alkhaibary A; Alharbi A; Khairy S
Surg Neurol Int; 2024; 15():34. PubMed ID: 38468661
[TBL] [Abstract][Full Text] [Related]
10. Disease spectrum of abnormal serum free light chain ratio and its diagnostic significance.
Xu B; Tang Y; Zhou J; Zhang P; Li H
Oncotarget; 2017 Oct; 8(47):82268-82279. PubMed ID: 29137262
[TBL] [Abstract][Full Text] [Related]
11. Enhancing diagnostic accuracy of multiple myeloma through ML-driven analysis of hematological slides: new dataset and identification model to support hematologists.
Andrade CLB; Ferreira MV; Alencar BM; Junior AMA; Lopes TJS; Dos Santos AS; Dos Santos MM; Silva MICS; Rosa IMDRP; Filho JLSB; Guimaraes MA; de Carvalho GC; Santos HHM; Santos MML; Meyer R; Rios TN; Rios RA; Freire SM
Sci Rep; 2024 May; 14(1):11176. PubMed ID: 38750071
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for patients with multiple myeloma admitted to the intensive care unit.
Diao X; Cai R; Luo J; Zheng Z; Zhan H
Hematology; 2020 Dec; 25(1):433-437. PubMed ID: 33210963
[No Abstract] [Full Text] [Related]
13. Lambda light chain predominance as a sign of emerging lymphoma.
Bray M; Alper MG
Am J Clin Pathol; 1983 Oct; 80(4):526-8. PubMed ID: 6414286
[TBL] [Abstract][Full Text] [Related]
14. Clonal heterogeneity by fluorescence in situ hybridization in multiple myeloma: enhanced cytogenetic risk stratification.
Abdel-Qader HY; Fouad DA; Abuelela SA; Ismail HMA; Boshnaq NH
Egypt J Med Hum Genet; 2022; 23(1):66. PubMed ID: 37521829
[TBL] [Abstract][Full Text] [Related]
15. The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma.
Warnnissorn AN; Treetipsatit J; Limvorapitak W
Hematology; 2020 Dec; 25(1):292-298. PubMed ID: 32772824
[No Abstract] [Full Text] [Related]
16. Immunohistological diagnosis of plasma cell myeloma based on cytoplasmic kappa/lambda ratio of CD138-positive plasma cells.
Nakayama-Ichiyama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Takayama A; Nishiwaki U; Masuda Y; Nishimura Y; Tsuji M; Hanafusa T
Leuk Lymphoma; 2012 Nov; 53(11):2205-9. PubMed ID: 22506669
[TBL] [Abstract][Full Text] [Related]
17. An approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/lambda ratios of CD38-gated CD138(+) cells.
Nakayama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Takayama A; Nishiwaki U; Masuda Y; Ikemoto T; Tanaka H; Nishimura Y; Tsuji M; Hanafusa T
Diagn Pathol; 2012 Sep; 7():131. PubMed ID: 23021410
[TBL] [Abstract][Full Text] [Related]
18. Immunohistological analysis in diagnosis of plasma cell myeloma based on cytoplasmic kappa/lambda ratio of CD38-positive plasma cells.
Nakayama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Nishiwaki U; Masuda Y; Hiraoka N; Takayama A; Nishimura Y; Tsuji M; Hanafusa T
Hematology; 2012 Nov; 17(6):317-20. PubMed ID: 23168070
[TBL] [Abstract][Full Text] [Related]
19. Dual Expression of Immunoglobulin Light Chains in Plasma Cell Myeloma: A Case Report and Literature Review.
Suresh J; Wu Y; Sabaratnam R; Brijlall S; Kyle B; Torlakovic EE
Appl Immunohistochem Mol Morphol; 2023 Aug; 31(7):447-451. PubMed ID: 36314594
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
